Skip to main content
. 2024 Nov 1;34:34. doi: 10.1038/s41533-024-00397-4

Fig. 7. Description of four analyses to evaluate the association of SABA prescriptions and SABA OTC purchase with asthma-related health outcomes in the SABINA III population (N = 4556).

Fig. 7

OTC over-the-counter, SABA short-acting β2-agonist, SABINA SABA use IN Asthma.